share_log

B of A Securities Maintains Buy on Xenon Pharmaceuticals, Raises Price Target to $56

B of A Securities Maintains Buy on Xenon Pharmaceuticals, Raises Price Target to $56

Bof A證券維持對Xenon Pharmicals的買入,將目標股價上調至56美元
Benzinga ·  01/02 10:48

B of A Securities analyst Jason Gerberry maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Buy and raises the price target from $52 to $56.

B of A Securities分析師傑森·格伯裏維持Xenon Pharmicals(納斯達克股票代碼:XENE)的買入並將目標股價從52美元上調至56美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論